Abstract
‘While drugs alone are not sufficient to provide adequate health care, they do play an important role in protecting, maintaining and restoring the health of people’ (WHO Expert Committee, 1977). Thus, ideally speaking the basic human needs such as fresh air, clean water, adequate food, heating and clothing, appropriate hygiene, sex and love should be satisfied before priorities are given to drugs. In practice we are aiming at establishing a reasonable balance by fulfilling — to the best of our ability — these basic prerequisites, as well as by providing appropriate drugs, as part of a total programme for promoting health and combating disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Controlling the Use of Therapeutic Drugs: An International Comparison (1978). Ed. Wardell, W. M. Washington D.C.: Enterprise Institute for Public Policy Research.
Darmanshah, I. (1978). Various drug problems in Indonesia’s health delivery system. Presented at: Lokaharya Penelitian dan Pengemabangan, Kesehatan, April 24–27.
Herman, F., Herxheimer, A. & Lionel, N. D. W. (1978). Package inserts for prescribed medicines: what minimum information do patients need? Brit. med. J., 2, 1132–1135.
Herxheimer, A. & Lionel, N. D. W. (1978). Minimum information needed by prescribers. Brit. med. J., 2, 1129–1132.
Journal World Medical Association (1978). Editorial WHO and the Pharmaceutical Industry. J. Wld. med. Ass., 25, 3.
Lancet (1978). Editorial WHO on essential drugs. Lancet, 2, 977.
Levy, M. (1980). Epidemiological evaluation of rare side effects on mild analgesics. In Mild Analgesics — a Re-Evaluation, in press.
Lunde, P. K. M. (1976). Differences in national drug-prescribing patterns. In Report from Symposium Clinical Pharmacological Evaluation in Drug Control, Deidesheim1975, pp. 19–47. Copenhagen: WHO Regional Office Europe.
Lunde, P. K. M. (1977a). Assignment Report, Clinical Pharmacology at Pahlavi University, Shiraz, Iran, 2 January–8 February 1977. (EM/PHARM/77).
Lunde, P. K. M. (1977b). Assignment Report, Drug Utilization in the Socialist People’s Libyan Arab Yamahiriya, Tripoli, Libya, 18 February–20March 1977. (EM/PHARM/76).
Lunde, P. K. M. (1979). Assignment Report, Drug Utilization Studies in People’s Democratic Republic of Yemen, 1–10 December. (EM/PHARM/86).
Lunde, P. K. M. (1980). Drug and product selection — an essential part of the therapeutic benefit/risk strategy? In Drug Induced Sufferings, National Congress Series No. 513, pp. 129–136. Amsterdam, Oxford, Princeton: Excerpta Medical.
Lunde, P. K. M. (1980). Assignment Report, the Selection of Essential Drugs in Indonesia. Jakarta, Indonesia, 12–21 June 1980. Geneva: WHO, in press.
Lunde, P. K. M., et al. (1979). Drug Utilization: Geographical Differences and Clinical Implications. In Advances in Pharmacology and Therapeutics, Vol. 6, Clinical Pharmacology, ed. Duchene Marullaz, P. pp. 77–170. Oxford, New York, Paris: Pergamon Press.
National Drug Policies (1979). Public Health in Europe 12. Copenhagen: WHO Regional Office for Europe.
Official Record World Health Organization (1975). Number 226, pp. 35–36, Annex 13, pp. 96–110.
Report of the Meeting on Technical Cooperation Among the Asean Countries on Drug Legislation, Evaluation and Quality Assurance (1979). Jakarta 26–29. November 1979, pp. 234–258.
Report of the WHO Regional Committee for South-East Asia (1979). Drug Policies Including Traditional Medicines in the Context of Primary Health Care. Report and Background Documentation of the Technical Discussions held during the Thirty-second Session of the WHO Regional Committee for South-East Asia, September 1979. WHO Regional Office for South-East Asia: New Delhi, November 1979.
Sjöqvist, F. (1975). Drug Utilization. In Proceedings VIth International Congress of Pharmacology, ed. Mattila, M. pp. 39–50. Helsinki 5: Finnish Pharmacological Society.
Studies in Drug Utilization. Methods and Applications (1979). Ed: Bergman, U., Grimsson, A., Wahba, A. H. W. & Westerholm, B. Copenhagen: WHO Regional Publications European Series No. 8.
The Alma-Ata Conference on Primary Health Care (1978). WHO Chronicle, 32, 409–430.
Tiefenbacher, M. (1977). In WHO’s Essential Drug List now being studied. Scrip, June 11, pp. 22–23.
Tognoni, G. (1978a). A therapeutic formulary for Italian general practitioners. Lancet, 1, 1352–1353.
Tognoni, G. (1978b). Assignment Report, Drug Policy and Selection of Essential Drugs in Saudi Arabia, July 1978 (EM/PHARM/81).
Tognoni, G., Colombo, F., Franzosi, G. & Garattini, S. (1980). Essential drugs, health needs, research in clinical pharmacology: Prospects and problems two years after publication of the WHO technical report 615. In Advances en Terapeutica, vol. 11, ed. Laporte J. & Salva, J. A. Salvar: Barcelona, in press.
WHO Expert Committee (1977). The Selection of Essential Drugs (first report). WHO Tech. Rep. Ser., no. 615, Geneva.
WHO Expert Committee (1979). The Selection of Essential Drugs (second report). WHO Tech. Rep. Ser., no. 641. Geneva.
WHO Regional Expert Committee (1977). Primary Health Care. AFRO. Tech. Rep. Ser., no. 3, Brazzaville.
WHO Regional Expert Committee (1979). South Pacific List of Essential Drugs 1st ed. WPRO: Manila.
Yudkin, J. S. (1978). Provision of medicines in a developing country. Lancet, 1, 810–812.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1980 The contributors
About this chapter
Cite this chapter
Lunde, P.K.M. (1980). The World Health Organization Essential Drug Concept — Three Years Afterwards. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_59
Download citation
DOI: https://doi.org/10.1007/978-1-349-05952-2_59
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-05954-6
Online ISBN: 978-1-349-05952-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)